Concurrent chemoradiotherapy versus radiotherapy alone after induction chemoimmunotherapy for stage III NSCLC patients who did not undergo surgery: a single institution retrospective study

BACKGROUND: With remarkable success and few side effects, induction chemoimmunotherapy has been used to improve the prognosis of patients with resectable or potentially resectable non-small cell lung cancer (NSCLC), even in stage III disease. However, for patients who are medically inoperable, unres...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Song, Ren, Kai, Zhang, Xuyu, Yan, Meng, Li, Xue, Zhao, Lujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367242/
https://www.ncbi.nlm.nih.gov/pubmed/37491257
http://dx.doi.org/10.1186/s13014-023-02305-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367242/
https://www.ncbi.nlm.nih.gov/pubmed/37491257
http://dx.doi.org/10.1186/s13014-023-02305-5

Ejemplares similares